BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6245704)

  • 1. Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s.
    Sim RB; Arlaud GJ; Colomb MG
    Biochim Biophys Acta; 1980 Apr; 612(2):433-49. PubMed ID: 6245704
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1s.
    Nilsson T; Wiman B
    Eur J Biochem; 1983 Jan; 129(3):663-7. PubMed ID: 6297891
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of purified C1 subcomponents, C1 inactivator and their complexes to immobilized heparin.
    McKay EJ; Johnson U; Laurell AB; Mårtensson U; Sjöholm AG
    Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):339-44. PubMed ID: 6274149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
    Bauer J; Valet G
    Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and properties of human C1 inhibitor.
    Sim RB; Reboul A
    Methods Enzymol; 1981; 80 Pt C():43-54. PubMed ID: 6281621
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of a complex of C1r and C1s subcomponents of human complement C1 by the third subcomponent C1q.
    Lin TY; Fletcher DS
    J Biol Chem; 1980 Aug; 255(16):7756-62. PubMed ID: 6249812
    [No Abstract]   [Full Text] [Related]  

  • 7. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the substrate binding site of human C1r and C1s with peptide thioesters. Development of new sensitive substrates.
    McRae BJ; Lin TY; Powers JC
    J Biol Chem; 1981 Dec; 256(23):12362-6. PubMed ID: 6271784
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement.
    Bally I; Rossi V; Lunardi T; Thielens NM; Gaboriaud C; Arlaud GJ
    J Biol Chem; 2009 Jul; 284(29):19340-8. PubMed ID: 19473974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid and efficient method for the purification of the complement subcomponents C1r and C1s in zymogen form using fast protein chromatography.
    Peitsch MC; Kovacsovics TJ; Isliker H
    J Immunol Methods; 1988 Apr; 108(1-2):265-9. PubMed ID: 2832479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium binding properties of the C1 subcomponents C1q, C1r and C1s.
    Villiers CL; Arlaud GJ; Painter RH; Colomb MG
    FEBS Lett; 1980 Aug; 117(1):289-94. PubMed ID: 6250896
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid phase activation of proenzymic C1r purified by affinity chromatography.
    Villiers CL; Duplaa AM; Arlaud GJ; Colomb MG
    Biochim Biophys Acta; 1982 Jan; 700(1):118-26. PubMed ID: 6275893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purified proenzyme C1r. Some characteristics of its activation and subsequent proteolytic cleavage.
    Arlaud GJ; Villiers CL; Chesne S; Colomb MG
    Biochim Biophys Acta; 1980 Nov; 616(1):116-29. PubMed ID: 6254570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma.
    Sim RB; Reboul A; Arlaud GJ; Villiers CL; Colomb MG
    FEBS Lett; 1979 Jan; 97(1):111-5. PubMed ID: 761607
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of the first component of complement.
    Schumaker VN; Zavodszky P; Poon PH
    Annu Rev Immunol; 1987; 5():21-42. PubMed ID: 3036181
    [No Abstract]   [Full Text] [Related]  

  • 19. C1 inhibitor: analysis of the role of amino acid residues within the reactive center loop in target protease recognition.
    Zahedi R; MacFarlane RC; Wisnieski JJ; Davis AE
    J Immunol; 2001 Aug; 167(3):1500-6. PubMed ID: 11466370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of the serine-protease subcomponents of C1: protein engineering studies.
    Gál P; Závodszky P
    Immunobiology; 1998 Aug; 199(2):317-26. PubMed ID: 9777415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.